CyberKnife Radiosurgery for Locally Recurrent Prostate CA
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00851916|
Recruitment Status : Unknown
Verified July 2017 by Carlyn Tripp, CyberKnife Centers of San Diego.
Recruitment status was: Recruiting
First Posted : February 26, 2009
Last Update Posted : July 21, 2017
The purpose of this study is to scientifically evaluate the effects (good and bad) of a new type of radiation treatment in patients with locally recurrent prostate cancer after prior radiotherapy. The treatment is known as prostate radiosurgery, and is distinguished from traditional radiotherapy by the application of smaller, more precisely controlled margins around the area targeted for full dose radiation, and far fewer treatments, using a much larger dose per treatment.
This research is being done to see what advantages, if any, prostate radiosurgery may have over other salvage treatment methods, including brachytherapy, cryosurgery, high intensity focused ultrasound (HIFU), hormonal therapy and radical prostatectomy.
|Condition or disease||Intervention/treatment||Phase|
|Recurrent Prostate Cancer||Radiation: CyberKnife Radiosurgery||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||VIRTUAL HDR CYBERKNIFE RADIOSURGERY FOR LOCALLY RECURRENT PROSTATIC CARCINOMA: A PHASE II STUDY|
|Study Start Date :||February 2009|
|Estimated Primary Completion Date :||February 2020|
Single arm study using CyberKnife radiosurgery to treat recurrent prostate cancer patients that have already received external beam radiotherapy.
Radiation: CyberKnife Radiosurgery
- Establish pattern of PSA decline [ Time Frame: Post CyberKnife Radiosurgery - 5 year f/up ]
- Quality of Life realitive to other commonly used radiation treatment methods for recurrent prostate cancer [ Time Frame: Post CyberKnife Radiosurgery/5 yr. f/up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00851916
|Contact: Carlyn Tripp||619-230-0400 ext firstname.lastname@example.org|
|United States, California|
|CybeKnife Centers of San Diego||Recruiting|
|San Diego, California, United States, 92024|
|Principal Investigator: Donald B. Fuller, M.D.|
|Principal Investigator:||Donald B Fuller, M.D.||CyberKnife Centers of San Diego|